<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">7707449</journal-id>
<journal-id journal-id-type="pubmed-jr-id">656</journal-id>
<journal-id journal-id-type="nlm-ta">Ann Neurol</journal-id>
<journal-id journal-id-type="iso-abbrev">Ann. Neurol.</journal-id>
<journal-title-group>
<journal-title>Annals of neurology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0364-5134</issn>
<issn pub-type="epub">1531-8249</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29630738</article-id>
<article-id pub-id-type="pmc">6021218</article-id>
<article-id pub-id-type="doi">10.1002/ana.25222</article-id>
<article-id pub-id-type="manuscript">NIHMS956631</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The epilepsy phenotypic spectrum associated with a recurrent <italic>CUX2</italic> variant</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Chatron</surname>
<given-names>Nicolas</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Møller</surname>
<given-names>Rikke S.</given-names>
</name>
<degrees>Ph.D</degrees>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Champaigne</surname>
<given-names>Neena L.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schneider MGenCouns</surname>
<given-names>Amy L.</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kuechler</surname>
<given-names>Alma</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Labalme</surname>
<given-names>Audrey</given-names>
</name>
<degrees>MS</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Simonet</surname>
<given-names>Thomas</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Baggett</surname>
<given-names>Lauren</given-names>
</name>
<degrees>MS</degrees>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bardel</surname>
<given-names>Claire</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kamsteeg</surname>
<given-names>Erik-Jan</given-names>
</name>
<degrees>Ph.D</degrees>
<xref ref-type="aff" rid="A8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pfundt</surname>
<given-names>Rolph</given-names>
</name>
<degrees>Ph.D</degrees>
<xref ref-type="aff" rid="A8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Romano</surname>
<given-names>Corrado</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Aronsson</surname>
<given-names>Johan</given-names>
</name>
<xref ref-type="aff" rid="A10">10</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Alberti</surname>
<given-names>Antonino</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vinci</surname>
<given-names>Mirella</given-names>
</name>
<xref ref-type="aff" rid="A9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Miranda</surname>
<given-names>Maria J.</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="A11">11</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lacroix</surname>
<given-names>Amy</given-names>
</name>
<degrees>BS</degrees>
<xref ref-type="aff" rid="A12">12</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Marjanovic</surname>
<given-names>Dragan</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>des Portes</surname>
<given-names>Vincent</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="A13">13</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Edery</surname>
<given-names>Patrick</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wieczorek</surname>
<given-names>Dagmar</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="A5">5</xref>
<xref ref-type="aff" rid="A14">14</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gardella</surname>
<given-names>Elena</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Scheffer</surname>
<given-names>Ingrid E.</given-names>
</name>
<degrees>MBBS, PhD</degrees>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="aff" rid="A15">15</xref>
<xref ref-type="aff" rid="A16">16</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mefford</surname>
<given-names>Heather</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="A12">12</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sanlaville</surname>
<given-names>Damien</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Carvill</surname>
<given-names>Gemma L.</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A17">17</xref>
<xref ref-type="author-notes" rid="FN2">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lesca</surname>
<given-names>Gaetan</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="author-notes" rid="FN2">*</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Department of Medical Genetics, Lyon University Hospital and GENDEV team CNRS UMR 5292, INSERM U1028, CRNL, and University Claude Bernard Lyon 1, GHE - Lyon - France</aff>
<aff id="A2">
<label>2</label>Danish Epilepsy Centre, Dianalund, and University of Southern Denmark, Institute for Regional Health research, Odense, Denmark</aff>
<aff id="A3">
<label>3</label>Greenwood Genetic Center, Greenwood, South Carolina, USA</aff>
<aff id="A4">
<label>4</label>Epilepsy Research Centre, Department of Medicine, Austin Health, University of Melbourne, Heidelberg, VIC, Australia</aff>
<aff id="A5">
<label>5</label>Institut für Humangenetik, Universitätsklinikum, and Universität Duisburg-Essen, Essen, Germany</aff>
<aff id="A6">
<label>6</label>Service de Biostatistique-Bioinformatique, Lyon University Hospital, Lyon and CNRS UMR5558, Laboratoire de Biométrie et Biologie Evolutive, Equipe Biostatistique Santé, Villeurbanne, and University Claude Bernard Lyon 1, Lyon, France</aff>
<aff id="A7">
<label>7</label>Centre de Biotechnologie Cellulaire, Hospices Civils de Lyon, Lyon, and Nerve-Muscle Interactions Team, Institut NeuroMyoGène CNRS UMR 5310 - INSERM U1217 - Université Claude Bernard Lyon 1, France</aff>
<aff id="A8">
<label>8</label>Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands</aff>
<aff id="A9">
<label>9</label>Oasi Research Institute – IRCCS, Troina, Italy</aff>
<aff id="A10">
<label>10</label>Habiliteringscentrum, Ryhov hospital, Jönköping, Sweden</aff>
<aff id="A11">
<label>11</label>Department of Pediatrics, Pediatric Neurology, Herlev University Hospital, Copenhagen, Denmark</aff>
<aff id="A12">
<label>12</label>Department of Pediatrics, Division of Genetic Medicine, University of Washington, Seattle, WA 98195 USA</aff>
<aff id="A13">
<label>13</label>Centre de référence « Déficiences Intellectuelles de causes rares », HCL, F-69675, Bron; ISC, CNRS UMR 5304, F-69677, Bron; Université de Lyon, F-69008, Lyon, France</aff>
<aff id="A14">
<label>14</label>Institut für Humangenetik, Universitätsklinikum Essen, Essen, and Institut für Humangenetik, Universitätsklinikum Düsseldorf, Düsseldorf, Germany</aff>
<aff id="A15">
<label>15</label>Florey Institute of Neuroscience and Mental Health, The University of Melbourne, VIC, Australia</aff>
<aff id="A16">
<label>16</label>Department of Paediatrics, Royal Children’s Hospital, The University of Melbourne, Parkville, Victoria, Australia</aff>
<aff id="A17">
<label>17</label>Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, 60611, USA</aff>
<author-notes>
<corresp id="FN1">Correspondance to: Gaetan Lesca, Service de Génétique, Groupement Hospitalier Est, 59 boulevard Pine, 69677 Bron, France. Tel: +33 4 72 12 96 39. Fax: +33 4 72 12 97 10. <email>gaetan.lesca@chu-lyon.fr</email> and Gemma Louise Carvill, Department of Neurology, Northwestern University Feinberg School of Medicine303 East Chicago Avenue, Ward 9-183 312-503-6187 (ph), <email>gemma.carvill@northwestern.edu</email></corresp>
<fn fn-type="equal" id="FN2">
<label>*</label>
<p>These two authors contributed equally to this work.</p>
</fn>
<fn fn-type="COI-statement" id="FN5">
<p>
<bold>POTENTIAL CONFLICTS OF INTEREST</bold>
</p>
<p>Nothing to report.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>3</day>
<month>4</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>30</day>
<month>4</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>5</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>5</month>
<year>2019</year>
</pub-date>
<volume>83</volume>
<issue>5</issue>
<fpage>926</fpage>
<lpage>934</lpage>
<!--elocation-id from pubmed: 10.1002/ana.25222-->
<abstract>
<sec id="S1">
<title>Objective</title>
<p id="P1">Cut homeodomain transcription factor CUX2 plays an important role in dendrite branching, spine development, and synapse formation in layer II–III neurons of the cerebral cortex. We identify a recurrent <italic>de novo CUX2</italic> p.Glu590Lys as a novel genetic cause for developmental and epileptic encephalopathy (DEE).</p>
</sec>
<sec id="S2">
<title>Methods</title>
<p id="P2">The <italic>de novo</italic> p.Glu590Lys variant was identified by whole-exome sequencing (n=5) or targeted gene panel (n=4). We performed electroclinical and imaging phenotyping on all patients.</p>
</sec>
<sec id="S3">
<title>Results</title>
<p id="P3">The cohort comprised 7 males and 2 females. Mean age at study was 13 years [0.5–21]. Median age at seizure onset was 6 months [2 months to 9 years]. Seizure types at onset were myoclonic, atypical absence with myoclonic components, and focal seizures. Epileptiform activity on EEG was seen in 8 cases: generalized polyspike-wave (6) or multifocal discharges (2). Seizures were drug-resistant in 7 or controlled with valproate (2). Six patients had a DEE: myoclonic DEE (3), Lennox-Gastaut syndrome (2) and West Syndrome (1). Two had a static encephalopathy and genetic generalized epilepsy, including absence epilepsy in one. One infant had multifocal epilepsy. Eight had severe cognitive impairment, with autistic features in six. The p.Glu590Lys variant affects a highly-conserved glutamine residue in the CUT domain predicted to interfere with CUX2 binding to DNA targets during neuronal development.</p>
</sec>
<sec id="S4">
<title>Interpretation</title>
<p id="P4">Patients with <italic>CUX2</italic> p.Glu590Lys display a distinctive phenotypic spectrum which is predominantly generalized epilepsy, with infantile-onset myoclonic DEE at the severe end and generalized epilepsy with severe static developmental encephalopathy at the milder end of the spectrum.</p>
</sec>
</abstract>
<kwd-group>
<kwd>intellectual disability</kwd>
<kwd>developmental and epileptic encephalopathy</kwd>
<kwd>myoclonic seizures</kwd>
<kwd>CUX2</kwd>
<kwd>CUT domain</kwd>
<kwd><italic>de novo</italic> variant</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>